BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

330 related articles for article (PubMed ID: 10823840)

  • 1. Tumor necrosis factor-alpha activation of NF-kappa B requires the phosphorylation of Ser-471 in the transactivation domain of c-Rel.
    Martin AG; Fresno M
    J Biol Chem; 2000 Aug; 275(32):24383-91. PubMed ID: 10823840
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of nuclear factor kappa B transactivation. Implication of phosphatidylinositol 3-kinase and protein kinase C zeta in c-Rel activation by tumor necrosis factor alpha.
    Martin AG; San-Antonio B; Fresno M
    J Biol Chem; 2001 May; 276(19):15840-9. PubMed ID: 11278885
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanism for biphasic rel A. NF-kappaB1 nuclear translocation in tumor necrosis factor alpha-stimulated hepatocytes.
    Han Y; Brasier AR
    J Biol Chem; 1997 Apr; 272(15):9825-32. PubMed ID: 9092517
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutation of an IKK phosphorylation site within the transactivation domain of REL in two patients with B-cell lymphoma enhances REL's in vitro transforming activity.
    Starczynowski DT; Trautmann H; Pott C; Harder L; Arnold N; Africa JA; Leeman JR; Siebert R; Gilmore TD
    Oncogene; 2007 Apr; 26(19):2685-94. PubMed ID: 17072339
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ser484 and Ser494 in REL are the major sites of IKK phosphorylation in vitro: evidence that IKK does not directly enhance GAL4-REL transactivation.
    Garbati MR; Gilmore TD
    Gene Expr; 2008; 14(4):195-205. PubMed ID: 19110719
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fibroblast growth factor-1 (FGF-1) enhances IL-2 production and nuclear translocation of NF-kappaB in FGF receptor-bearing Jurkat T cells.
    Byrd VM; Ballard DW; Miller GG; Thomas JW
    J Immunol; 1999 May; 162(10):5853-9. PubMed ID: 10229820
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutations of tumor necrosis factor alpha-responsive serine residues within the C-terminal transactivation domain of human transcription factor REL enhance its in vitro transforming ability.
    Starczynowski DT; Reynolds JG; Gilmore TD
    Oncogene; 2005 Nov; 24(49):7355-68. PubMed ID: 16027730
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Basal phosphorylation of the PEST domain in the I(kappa)B(beta) regulates its functional interaction with the c-rel proto-oncogene product.
    Chu ZL; McKinsey TA; Liu L; Qi X; Ballard DW
    Mol Cell Biol; 1996 Nov; 16(11):5974-84. PubMed ID: 8887627
    [TBL] [Abstract][Full Text] [Related]  

  • 9. NF-kappaB-inducing kinase is involved in the activation of the CD28 responsive element through phosphorylation of c-Rel and regulation of its transactivating activity.
    Sánchez-Valdepeñas C; Martín AG; Ramakrishnan P; Wallach D; Fresno M
    J Immunol; 2006 Apr; 176(8):4666-74. PubMed ID: 16585559
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heme oxygenase-1-derived carbon monoxide requires the activation of transcription factor NF-kappa B to protect endothelial cells from tumor necrosis factor-alpha-mediated apoptosis.
    Brouard S; Berberat PO; Tobiasch E; Seldon MP; Bach FH; Soares MP
    J Biol Chem; 2002 May; 277(20):17950-61. PubMed ID: 11880364
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rel/NF-kappaB can trigger the Notch signaling pathway by inducing the expression of Jagged1, a ligand for Notch receptors.
    Bash J; Zong WX; Banga S; Rivera A; Ballard DW; Ron Y; Gélinas C
    EMBO J; 1999 May; 18(10):2803-11. PubMed ID: 10329626
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanism responsible for T-cell antigen receptor- and CD28- or interleukin 1 (IL-1) receptor-initiated regulation of IL-2 gene expression by NF-kappaB.
    Kalli K; Huntoon C; Bell M; McKean DJ
    Mol Cell Biol; 1998 Jun; 18(6):3140-8. PubMed ID: 9584155
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Disruption of NF-kappaB signaling reveals a novel role for NF-kappaB in the regulation of TNF-related apoptosis-inducing ligand expression.
    Baetu TM; Kwon H; Sharma S; Grandvaux N; Hiscott J
    J Immunol; 2001 Sep; 167(6):3164-73. PubMed ID: 11544302
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Persistent activation of NF-kappa B/Rel by human T-cell leukemia virus type 1 tax involves degradation of I kappa B beta.
    Good L; Sun SC
    J Virol; 1996 May; 70(5):2730-5. PubMed ID: 8627746
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phosphorylation of IkappaBalpha in the C-terminal PEST domain by casein kinase II affects intrinsic protein stability.
    Lin R; Beauparlant P; Makris C; Meloche S; Hiscott J
    Mol Cell Biol; 1996 Apr; 16(4):1401-9. PubMed ID: 8657113
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A new member of the I kappaB protein family, I kappaB epsilon, inhibits RelA (p65)-mediated NF-kappaB transcription.
    Li Z; Nabel GJ
    Mol Cell Biol; 1997 Oct; 17(10):6184-90. PubMed ID: 9315679
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation of nuclear factor-kappaB-dependent transcription by tumor necrosis factor-alpha is mediated through phosphorylation of RelA/p65 on serine 529.
    Wang D; Baldwin AS
    J Biol Chem; 1998 Nov; 273(45):29411-6. PubMed ID: 9792644
    [TBL] [Abstract][Full Text] [Related]  

  • 18. I kappa B/MAD-3 masks the nuclear localization signal of NF-kappa B p65 and requires the transactivation domain to inhibit NF-kappa B p65 DNA binding.
    Ganchi PA; Sun SC; Greene WC; Ballard DW
    Mol Biol Cell; 1992 Dec; 3(12):1339-52. PubMed ID: 1493333
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tumor necrosis factor alpha-induced phosphorylation of RelA/p65 on Ser529 is controlled by casein kinase II.
    Wang D; Westerheide SD; Hanson JL; Baldwin AS
    J Biol Chem; 2000 Oct; 275(42):32592-7. PubMed ID: 10938077
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential regulation of p65 and c-Rel NF-kappaB transactivating activity by Cot, protein kinase C zeta and NIK protein kinases in CD3/CD28 activated T cells.
    Sánchez-Valdepeñas C; Punzón C; San-Antonio B; Martin AG; Fresno M
    Cell Signal; 2007 Mar; 19(3):528-37. PubMed ID: 17070014
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.